Journals / Nöropsikiyatri Arşivi / 2015 / Cilt: 52 - Sayı: 2

Tardive Blepharospasm and Meige Syndrome during Treatment with Quetiapine and Olanzapine

Ketiapin ve Olanzapin Tedavisi Sırasında Ortaya Çıkan Meige Sendromu ve Tardif Blefarospazm

Pages
207–209
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As reported below, a patient with an affective disorder who had quetiapine-induced oromandibular dystonia and olanzapine-induced Meige syndrome after antipsychotic augmentation in different stages of the disease process was presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Meige syndrome, which has been presented in tardive syndromes, is a form of blepharospasm accompanied by oromandibular dystonia with manifestations over the face, jaw, and neck.
📊
Key Findings & Data:Atypical antipsychotics have less extrapyramidal side effects because of a weak dopamine D2 receptor binding affinity or a strong antagonistic effect to serotonin 5-HT2a receptor and have been known to cause less tardive dyskinesia than typical antipsychotics.
💡
Conclusion & Impact:As reported below, a patient with an affective disorder who had quetiapine-induced oromandibular dystonia and olanzapine-induced Meige syndrome after antipsychotic augmentation in different stages of the disease process was presented.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Meige syndrome, which has been presented in tardive syndromes, is a form of blepharospasm accompanied by oromandibular dystonia with manifestations over the face, jaw, and neck. A blepharospasm can be induced by antihistamines, dopaminomimetic or sympathomimetic drugs, or long-term exposure to dopamine antagonists. Atypical antipsychotics have less extrapyramidal side effects because of a weak dopamine D2 receptor binding affinity or a strong antagonistic effect to serotonin 5-HT2a receptor and have been known to cause less tardive dyskinesia than typical antipsychotics. Thus, in literature, atypical antipsychotics are recommended for the treatment of psychosis in cases of tardive dyski nesia. The potential risk factors associated with the development of tardive dyskinesia are extrapyramidal symptoms' history, diabetes mellitus, affective disorder, female gender, older age, and long-term therapy with neuroleptics at higher dosages. As reported below, a patient with an affective disorder who had quetiapine-induced oromandibular dystonia and olanzapine-induced Meige syndrome after antipsychotic augmentation in different stages of the disease process was presented.

Özet

Tardif sendromlar içinde yer alan Meige sendromu, blefarospazm ile birlikte yüz, çene ya da boyunda oromandibular distoninin görüldüğü durumdur. Blefarospazm; antihistaminik, dopaminerjik, sempatomimetik ajanların kullanılması ya da dopamin antagonistlerinin uzun süre kullanımıyla oluşabilmektedir. Atipik antipsikotikler dopamin D-2 reseptörlerine daha düşük afinite ile bağlanmaları ya da serotonin 5-HT2a reseptörlerine olan güçlü antagonistik etkileri nedeniyle daha az ekstrapiramidal yan etki oluşturur ve tipik antipsikotiklere oranla daha az tardif diskineziye neden olduğu düşünülmektedir. Bu nedenle literatürde; tardif diskinezi gelişen psikotik hastaların tedavisinde atipik antipsikotiklerin kullanımı önerilmektedir. Tardif diskinezinin ortaya çıkmasında en önemli risk etmenleri arasında kişinin daha önce ekstrapiramidal belirti göstermiş olması, diabetes mellitus, afektif bozukluklar, kadın cinsiyet, ileri yaş, uzun süreli ve yüksek dozda nöroleptik kullanımı yer almaktadır. Aşağıda; hastalık sürecinin farklı dö- nemlerinde tedaviye atipik antipsikotik eklenmesiyle, ketiapin kullanımına bağlı oromandibular distoni ve olanzapin kullanımına bağlı Meige sendromu gelişen bir duygudurum bozukluğu hastası sunulmuştur.

🔖

Cite This Article

KILIÇ, A., ERTEN, E., ÖZDEMİR, A. (2015). Tardive Blepharospasm and Meige Syndrome during Treatment with Quetiapine and Olanzapine. Nöropsikiyatri Arşivi, Cilt: 52 - Sayı: 2, 207–209. https://ajindex.com/articles/294396

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Lerner V, Miodownik C. Motor symptoms of schizophrenia: is tardive dyskine- sia a symptom or side effect? A modern treatment. Curr Psychiatry Rep 2011; 13:295-304. [CrossRef] Sachdev P. Tardive blepharospasm. Mov Disord 1998; 13:947-951. [CrossRef] van Harten PN, Matroos GE, Van Os J. The course of tardive dystonia in Afro Caribbean patients, a population-based study: the Curacao extrapyramidal syndromes study: VII. Schizophr Res 2008; 98:79-83. [CrossRef] Lee Y, Yeh WC, Chong MY, Lin PY, Chang YY. Venlafaxine and tardive bleph- arospasm: a case report. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:1139-1140. [CrossRef] Duggal HS, Mendhekar DN. Clozapine-induced tardive dystonia (blepharo- spasm). J Neuropsychiatry Clin Neurosci 2007; 19:86-87. [CrossRef] Miyamoto S, Duncan GE, Marx CE, Lieberman JA. Treatments for schizophre- nia: a critical review of pharmacology and mechanisms of action of antipsy- chotic drugs. Mol Psychiatry 2005; 10:79-104. [CrossRef] Tenback DE, van Harten PN, Slooff CJ, van Os J. Incidence and persistence of tardive dyskinesia and extrapyramidal symptoms in schizophrenia. J Psycho- pharmacol 2010; 24:1031-1035. [CrossRef] Woods SW, Morgenstern H, Saksa JR, Walsh BC, Sullivan MC, Money R, Haw- kins KA, Gueorguieva RV, Glazer WM. Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study. J Clin Psychiatry 2010; 71:463-474. [CrossRef] Casey DE. Tardive dyskinesia and atypical antipsychotic drugs. Schizophr Res 1999; 35:61-66. [CrossRef] Tarsy D, Baldessarini JR. Epidemiology of tardive dyskinesia: Is risk declining with modern antipsychotics? Mov Disord 2006; 21:589-598. [CrossRef] Reeves RR, Liberto V. Treatment of essential blepharospasm with quetiapine. Mov Disord 2003; 18:1072-1073. [CrossRef] Lucetti C, Bellini G, Nuti A, Bernardini S, Dell'Agnello G, Piccinni A, Maggi L, Manca L, Bonuccelli U. Treatment of patients with tardive dystonia with olanzapine. Clin Neuropharmacol 2002; 25:71-74. [CrossRef] Fukui H, Murai T. Marked Improvement of Meige's syndrome with olanzapine in a schizophrenic patient. J of Neuropsych and Clin Neurosciences 2002; 14:355-356. [CrossRef] Ananth J, Kenan J. Tardive dyskinesia associated with olanzapine monotherapy. J Clin Psychiatry 1999; 60:870. [CrossRef] Charfi F, Cohen D, Houeto JL, Soubre C, Mazet P. Tardive Dystonia induced by atypical neuroleptics: a case report with olanzapine. J Child Adolesc Psycho- pharmacol 2004; 14:149-152.